Surgical Neurology Branch, NINDS, National Institutes of Health, Bethesda, Maryland.
Novant Health Neurosurgery Specialists, Charlotte, North Carolina.
Neurosurgery. 2019 Feb 1;84(2):457-468. doi: 10.1093/neuros/nyy072.
The origin of syrinx fluid is controversial.
To elucidate the mechanisms of syringomyelia associated with cerebrospinal fluid pathway obstruction and with intramedullary tumors, contrast transport from the spinal subarachnoid space (SAS) to syrinx was evaluated in syringomyelia patients.
We prospectively studied patients with syringomyelia: 22 with Chiari I malformation and 16 with SAS obstruction-related syringomyelia before and 1 wk after surgery, and 9 with tumor-related syringomyelia before surgery only. Computed tomography-myelography quantified dye transport into the syrinx before and 0.5, 2, 4, 6, 8, 10, and 22 h after contrast injection by measuring contrast density in Hounsfield units (HU).
Before surgery, more contrast passed into the syrinx in Chiari I malformation-related syringomyelia and spinal obstruction-related syringomyelia than in tumor-related syringomyelia, as measured by (1) maximum syrinx HU, (2) area under the syrinx concentration-time curve (HU AUC), (3) ratio of syrinx HU to subarachnoid cerebrospinal fluid (CSF; SAS) HU, and (4) AUC syrinx/AUC SAS. More contrast (AUC) accumulated in the syrinx and subarachnoid space before than after surgery.
Transparenchymal bulk flow of CSF from the subarachnoid space to syrinx occurs in Chiari I malformation-related syringomyelia and spinal obstruction-related syringomyelia. Before surgery, more subarachnoid contrast entered syringes associated with CSF pathway obstruction than with tumor, consistent with syrinx fluid originating from the subarachnoid space in Chiari I malformation and spinal obstruction-related syringomyelia and not from the subarachnoid space in tumor-related syringomyelia. Decompressive surgery opened subarachnoid CSF pathways and reduced contrast entry into syringes associated with CSF pathway obstruction.
关于脊液囊肿液的来源一直存在争议。
为了阐明与脑脊液通路梗阻和脊髓内肿瘤相关的脊髓空洞症的发病机制,我们评估了脊髓空洞症患者的脊髓蛛网膜下腔(SAS)与脊液囊肿之间的对比转运情况。
我们前瞻性地研究了脊髓空洞症患者:22 例 Chiari I 畸形患者和 16 例 SAS 梗阻性脊髓空洞症患者分别在手术前和手术后 1 周进行研究,9 例肿瘤相关性脊髓空洞症患者仅在手术前进行研究。通过测量 Hounsfield 单位(HU)中的对比密度,计算 CT 脊髓造影在对比注射前和 0.5、2、4、6、8、10 和 22 h 后进入脊液囊肿的染料转运量。
手术前,与肿瘤相关性脊髓空洞症相比,Chiari I 畸形相关脊髓空洞症和 SAS 梗阻性脊髓空洞症患者的脊液囊肿中更多的对比剂通过(1)最大脊液囊肿 HU、(2)脊液囊肿浓度时间曲线下面积(HU AUC)、(3)脊液囊肿与蛛网膜下腔脑脊液(SAS)HU 的比值和(4)脊液囊肿 AUC/SAS AUC,更多的对比剂(AUC)在脊液囊肿和蛛网膜下腔中积聚。
在 Chiari I 畸形相关脊髓空洞症和 SAS 梗阻性脊髓空洞症中,CSF 从蛛网膜下腔通过实质向脊液囊肿的 bulk 流动。手术前,与肿瘤相关的脊髓空洞症相比,更多的蛛网膜下腔对比剂进入与 CSF 通路梗阻相关的脊髓空洞症,这与 Chiari I 畸形和 SAS 梗阻性脊髓空洞症的脊液囊肿液来源于蛛网膜下腔,而不是肿瘤相关的脊髓空洞症的脊液囊肿液来源于蛛网膜下腔的结论一致。减压手术开放了蛛网膜下腔 CSF 通路,减少了与 CSF 通路梗阻相关的脊髓空洞症的对比剂进入。